Progress in perisynaptic Schwann cell and neuromuscular junction research

QR Code

Progress in perisynaptic Schwann cell and neuromuscular junction research

Enregistré dans:

Détails bibliographiques
Auteur principal:	Chandler L Walker
Format:	article
Langue:	EN
Publié:	Wolters Kluwer Medknow Publications 2022
Sujets:	Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/5e4ca92a67d644d598ac05a2bf0d9520
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Coordination of Schwann cell myelination and node formation at the transcriptional level
par: Franziska Frob, et autres
Publié: (2022)

Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders)
par: El Tallawy HN, et autres
Publié: (2016)

Editorial: Imaging of Neuromuscular Diseases
par: Jordi Diaz-Manera, et autres
Publié: (2021)

Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
par: Abigail L. Pfaff, et autres
Publié: (2021)

Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America
par: Anna Naito, et autres
Publié: (2021)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
par: Luis M. A. Oliveira, et autres
Publié: (2021)

The Gordon Research Seminar & Conference on Parkinson’s disease: state of the Science 200 years after James Parkinson’s essay on the Shaking Palsy
par: J. T. Greenamyre, et autres
Publié: (2017)

Surgical Treatment of Metastatic Lesions at the Cervicothoracic Spinal Junction
par: Tariq Awad, et autres
Publié: (2017)

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson’s disease (LARGE-PD), a case of ancestry
par: Mario Cornejo-Olivas, et autres
Publié: (2017)

LRRK2 levels in immune cells are increased in Parkinson’s disease
par: D. A. Cook, et autres
Publié: (2017)

Targeting collective behaviors of transplanted retinal cells as a strategy to improve cellular integration
par: Miles Markey, et autres
Publié: (2022)

Retinal ganglion cell protection by hop-flower extract as a novel neuroprotective strategy for glaucoma
par: Tomoko Hasegawa, et autres
Publié: (2022)

Non-cell autonomous role of astrocytes in axonal degeneration of cortical projection neurons in hereditary spastic paraplegias
par: Xue-Jun Li
Publié: (2022)

Preterm neonatal brain injury: are human amnion epithelial stem cells a pan-treatment for neuroprotection and neurorepair?
par: Joanne O Davidson, et autres
Publié: (2022)

Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
par: Hua-Ying Cai, et autres
Publié: (2021)

Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells
par: Jeong-Eun Yoo, et autres
Publié: (2021)

Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
par: Faith L. Anderson, et autres
Publié: (2021)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
par: E. Giusto, et autres
Publié: (2021)

TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
par: Megan C. Bakeberg, et autres
Publié: (2021)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
par: J. M. Hatcher-Martin, et autres
Publié: (2021)

Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
par: Franziska Albrecht, et autres
Publié: (2017)

Validation of the XDP–MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism
par: Paul Matthew D. Pasco, et autres
Publié: (2017)

Clinician’s perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience
par: Diego Kaski, et autres

Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20
par: Briana R. De Miranda, et autres
Publié: (2020)

Irritable bowel syndrome and Parkinson’s disease risk: register-based studies
par: Bojing Liu, et autres
Publié: (2021)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
par: Souvarish Sarkar, et autres
Publié: (2020)

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
par: A. Castrioto, et autres
Publié: (2020)

A real-world study of wearable sensors in Parkinson’s disease
par: Jamie L. Adams, et autres
Publié: (2021)

Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau
par: Benjamin J. Kim, et autres
Publié: (2021)

Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease
par: Dominic J Hare, et autres
Publié: (2017)

Microdialysis and microperfusion electrodes in neurologic disease monitoring
par: Luke A. Stangler, et autres
Publié: (2021)

Correction to: Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes
par: Adan Hernandez, et autres
Publié: (2021)

Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors
par: Laine Thomas, et autres
Publié: (2021)

Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
par: Chun Chen, et autres
Publié: (2021)

Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors
par: Anthony R. Braun, et autres
Publié: (2021)

Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
par: G. Carola, et autres
Publié: (2021)

Fine mapping of the HLA locus in Parkinson’s disease in Europeans
par: Eric Yu, et autres
Publié: (2021)

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
par: Caroline M. Tanner, et autres
Publié: (2021)

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
par: Howard E. Gendelman, et autres
Publié: (2017)

Guardians of the eye: new tales about retinal microglia and other ocular macrophages
par: Dennis-Dominik Rosmus, et autres
Publié: (2022)